1Life Healthcare, Inc.
1Life Healthcare, Inc. (ONEM) Stock Overview
Explore 1Life Healthcare, Inc.’s financial performance, market position, analyst ratings, and future outlook.
ONEM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of 1Life Healthcare, Inc. (ONEM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $4.73.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.16 and a market capitalization of 3.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.
Mr. Amir Dan Rubin MBA
3,090
One Embarcadero Center, San Francisco, CA
2020